Format

Send to

Choose Destination
See comment in PubMed Commons below
Pediatr Infect Dis J. 1996 May;15(5):456-60.

Rapid oral desensitization to trimethoprim-sulfamethoxazole in infants and children.

Author information

1
Department of Pediatrics, New York University School of Medicine, Bellevue Hospital Center, NY, USA.

Abstract

BACKGROUND:

Although trimethoprim-sulfamethoxazole is the preferred chemoprophylaxis against Pneumocystis carinii pneumonia, there are frequent IgE-mediated reactions among children infected with the human immunodeficiency virus (HIV). Oral desensitization allows more patients to receive chemoprophylaxis, but it has been studied in only a limited number of children.

METHODS:

We desensitized five children infected with the HIV using a rapid, 4-h oral protocol.

RESULTS:

Three children (including two infants) successfully completed desensitization and started maintenance therapy, but the other two experienced reactions that precluded further administration of trimethoprim-sulfamethoxazole.

CONCLUSIONS:

We conclude that a rapid, oral trimethoprim-sulfamethoxazole desensitization protocol is safe and, in some instances, effective among HIV-infected children and infants with a history of non-life-threatening, IgE-mediated reactions to trimethoprim-sulfamethoxazole.

PMID:
8724071
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wolters Kluwer
    Loading ...
    Support Center